{
    "clinical_study": {
        "@rank": "5013", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Capsules containing 250 mg of placebo, two times a day"
            }, 
            {
                "arm_group_label": "BioTurmin", 
                "arm_group_type": "Experimental", 
                "description": "Capsules containing 250 mg of BioTurmin (Curcuma longa rhizomes extract), two times a day"
            }, 
            {
                "arm_group_label": "BioTurmin-WD", 
                "arm_group_type": "Experimental", 
                "description": "Capsules containing 250 mg of BioTurmin-WD (water dispersible curcuminoids), two times a day"
            }, 
            {
                "arm_group_label": "MaQxan", 
                "arm_group_type": "Experimental", 
                "description": "Capsules containing 10 mg of MaQxan (Tagetes erecta flower extract), two times a day"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the efficacy and safety of dietary supplements\n      (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in\n      chronic smokers having mild to moderate hyperlipidemia after 30 days of intervention."
        }, 
        "brief_title": "Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Smokers", 
            "Hyperlipidemia"
        ], 
        "condition_browse": {
            "mesh_term": "Hyperlipidemias"
        }, 
        "detailed_description": {
            "textblock": "In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary\n      supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers\n      having mild to moderate hyperlipidemia. Sixty subjects will be randomly assigned to receive\n      the dietary supplements and placebo for 30 days. The efficacy of the supplements will be\n      measured by estimating cotinine and malondialdehyde level."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Men > 20 years\n\n        Chronic cigarette/ beedi smoker (2-3 packets/day since last 3 years or more) with mild to\n        moderate hyperlipidemia (LDL ranging 160-189 mg/dL, TC >200 mg/dL and/or HDL-C <40 mg/dL)\n\n        Being mentally competent and able to understand all study requirements and sign the\n        informed consent form.\n\n        Exclusion Criteria:\n\n        Patients with Chronic obstructive pulmonary disease (COPD)\n\n        Women\n\n        Patients with severe liver, renal, cardiac or brain diseases.\n\n        Unable to complete follow up.\n\n        Subjects on any medication like diuretics.\n\n        Allergic to any medication.\n\n        With a history of alcohol and/or drug abuse."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02100202", 
            "org_study_id": "OLS-SH/02-14 Ver 01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "BioTurmin", 
                "intervention_name": "BioTurmin (Curcuma longa rhizomes extract)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "BioTurmin-WD", 
                "intervention_name": "BioTurmin-WD (Water dispersible curcuminoids)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "MaQxan", 
                "intervention_name": "MaQxan (Tagetes erecta flower extract)", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dietary supplements", 
            "Cotinine level", 
            "Malondialdehyde", 
            "Chronic smokers", 
            "Hyperlipidemia"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "link": [
            {
                "description": "Turmeric extract", 
                "url": "http://dsld.nlm.nih.gov/dsld/Ingredient.jsp?db=adsld%2C&item=TURMERIC%20EXTRACT"
            }, 
            {
                "description": "Dietary supplements", 
                "url": "http://www.nlm.nih.gov/medlineplus/dietarysupplements.html"
            }
        ], 
        "location": {
            "contact": {
                "email": "drvenkatesh64@gmail.com", 
                "last_name": "Venkateshwarlu K, MD (Ayur)", 
                "phone": "919945232107"
            }, 
            "contact_backup": {
                "email": "drkrraveendra@gmail.com", 
                "last_name": "Raveendra K R, MD", 
                "phone": "919448134587"
            }, 
            "facility": {
                "address": {
                    "city": "Bangalore", 
                    "country": "India", 
                    "state": "Karnataka", 
                    "zip": "560050"
                }, 
                "name": "Sreenivasa Clinic Diabetic Research Center"
            }, 
            "investigator": [
                {
                    "last_name": "Raveendra K R, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Venkateshwarlu K, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "4", 
        "official_title": "Efficacy and Safety Study of Dietary Supplements (BioTurmin, BioTurmin-WD and MaQxan) on Cotinine Level and Oxidative Stress Marker in Chronic Smokers Having Mild to Moderate Hyperlipidemia", 
        "other_outcome": {
            "description": "Physical and clinical laboratory evaluations - Electrocardiogram (ECG), haematology [complete blood count (CBC)], biochemical tests (serum urea, serum creatinine), liver function test and urine analysis", 
            "measure": "Safety and tolerability (composite measure)", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline and on day 30"
        }, 
        "overall_contact": {
            "email": "shiv@olivelifesciences.com", 
            "last_name": "Shivaprasad H N, M Pharma, Ph.D", 
            "phone": "918971489704"
        }, 
        "overall_contact_backup": {
            "email": "bhanumathy@olivelifesciences.com", 
            "last_name": "Bhanumathy M, M Pharma", 
            "phone": "919986411152"
        }, 
        "overall_official": {
            "affiliation": "Sreenivasa Clinic Diabetic Research Center", 
            "last_name": "Venkateshwarlu K, MD (Ayur)", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Drugs Controller General of India", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "nicotine metabolite (cotinine)  and serum oxidative stress marker (malondialdehyde) levels", 
            "measure": "Change in urine cotinine and serum oxidative stress marker levels", 
            "safety_issue": "No", 
            "time_frame": "Baseline and on day 30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02100202"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Low density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-cholesterol (VLDL-C), high density lipoprotein-cholesterol (HDL-C), total cholesterol (TC)", 
            "measure": "Change in serum lipid profile", 
            "safety_issue": "No", 
            "time_frame": "Baseline and on day 30"
        }, 
        "source": "Olive Lifesciences Pvt Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Olive Lifesciences Pvt Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}